Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$460M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$294M |
| 4 |
Tesla
TSLA
|
+$276M |
| 5 |
Caterpillar
CAT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 3 |
Lowe's Companies
LOW
|
+$663M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$404M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.68% |
| 2 | Healthcare | 6.62% |
| 3 | Financials | 5.53% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Watsco Inc
WSO
$15.1B
| $6.97M | 0.01% |
27,948
-11,354
| -29% | -$2.99M |
|
1302
Carlisle Companies
CSL
$14.1B
| $6.96M | 0.01% |
29,532
-10,948
| -27% | -$2.82M |
|
1303
iShares MSCI EAFE Growth ETF
EFG
$16.3B
| $6.96M | 0.01% |
83,046
-2,620
| -3% | -$212K |
|
|
VTLE
1304
DELISTED
Vital Energy
VTLE
| $6.93M | 0.01% |
134,676
+54,317
| +68% | +$3.35M |
|
|
CFLT
1305
DELISTED
Confluent
CFLT
| $6.9M | 0.01% |
310,259
+35,310
| +13% | +$818K |
|
1306
PUT
DuPont de Nemours
DD
$19B
| $6.86M | 0.01% |
79,667
| – | – |
|
|
ETNB
1307
DELISTED
89bio
ETNB
| $6.86M | 0.01% |
538,679
+128,032
| +31% | +$1.15M |
|
1308
Teva Pharmaceuticals
TEVA
$36.9B
| $6.85M | 0.01% |
751,596
-458,241
| -38% | -$4M |
|
1309
CALL
Okta
OKTA
$23.7B
| $6.83M | 0.01% |
100,000
| – | – |
|
|
NKLA
1310
DELISTED
Nikola Corporation Common Stock
NKLA
| $6.83M | 0.01% |
105,428
+103,021
| +4,280% | +$8.61M |
|
1311
Rio Tinto
RIO
$149B
| $6.82M | 0.01% |
95,761
+10,116
| +12% | +$635K |
|
1312
Ingevity
NGVT
$2.59B
| $6.78M | 0.01% |
96,223
+7,061
| +8% | +$498K |
|
1313
Syndax Pharmaceuticals
SNDX
$1.74B
| $6.77M | 0.01% |
265,933
-265,053
| -50% | -$6.18M |
|
1314
Palantir
PLTR
$296B
| $6.75M | 0.01% |
1,050,885
-254,681
| -20% | -$1.93M |
|
1315
Bio-Techne
TECH
$11.2B
| $6.71M | 0.01% |
81,011
-16,229
| -17% | -$1.29M |
|
1316
Arrow Electronics
ARW
$10.8B
| $6.7M | 0.01% |
64,067
-11,248
| -15% | -$1.16M |
|
1317
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $6.69M | 0.01% |
135,185
+27,259
| +25% | +$1.34M |
|
1318
First Trust Preferred Securities and Income ETF
FPE
$6.33B
| $6.68M | 0.01% |
397,858
-82,761
| -17% | -$1.39M |
|
1319
Bio-Rad Laboratories Class A
BIO
$8.86B
| $6.67M | 0.01% |
15,854
-2,287
| -13% | -$923K |
|
1320
Caesars Entertainment
CZR
$6.1B
| $6.66M | 0.01% |
159,979
-126,763
| -44% | -$5.64M |
|
1321
Fortis
FTS
$29.7B
| $6.64M | 0.01% |
166,126
-29,121
| -15% | -$1.14M |
|
1322
DaVita
DVA
$15.4B
| $6.64M | 0.01% |
88,874
+21,750
| +32% | +$1.69M |
|
1323
CALL
Valvoline
VVV
$5.13B
| $6.61M | 0.01% |
+202,300
| New | +$6.12M |
|
1324
Roku
ROKU
$21.3B
| $6.6M | 0.01% |
162,235
-240,604
| -60% | -$12.6M |
|
1325
Strategy Inc
MSTR
$35.1B
| $6.59M | 0.01% |
465,280
+436,260
| +1,503% | +$8.92M |
|
Similar funds
Citigroup's Q4 2022 Portfolio in Review
As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.
- Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
- Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
- Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
- Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
- Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
- Citigroup opened 309 new positions and closed 469 in Q4 2022.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.